Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SOLIGENIX, INC.
Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
May 1, 2026
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet’s Disease
April 29, 2026
Soligenix to Present at BIO Investment & Growth Summit
April 28, 2026
Soligenix Details Recent Progress and Upcoming Milestones
March 10, 2026
←
Previous Page
1
2